Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 11
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

APC/C-Cdh1-Rock2 pathway controls dentritic integrity and memory

  • Bobo-Jimenez, Veronica
  • Delgado-Esteban, María
  • Sánchez Morán, Irene
  • Almeida, Angeles
Trabajo presentado en el 17º Congreso Nacional de la Sociedad Española de Neurociencia, celebrado en Valencia (España), del 27 al 30 de septiembre de 2017, [Background] The correct formation and long-term maintenance of the dendritic network are essential for the normal functioning of the brain. In the adult brain, dendrite stability confers mature neurons the ability to maintain long-term dendritic arbor integrity and integration within networks. Dendritic disruption and loss of dendritic spines and synapses have been reported in neurodegenerative conditions, including Alzheimer’s disease (AD). [Material and methods] We first generated CamKIIalpha-Cre-mediated Cdh1 conditional knockout mice (Cdh1 cKO) for the depletion of Cdh1 in glutamatergic neurons of the cortex and hippocampus from the adult brain. Double-transgenic Cdh1 cKO mice were crossed with Thy1-YFP-H animals, which express yellow fluorescent protein in the pyramidal neurons of the previously mentioned areas. To inhibit Rock activity, fasudil (20 mg/kg body weight; 60 days) was injected intraperitoneally every other day into 30-day-old mice. [Results] Here we show that postnatal deletion of Cdh1, a cofactor of the anaphase promoting complex/cyclosome (APC/C) ubiquitin ligase in neurons (Cdh1 cKO), disrupts dendrite arborization and causes dendritic spine and synapse loss in the cortex and hippocampus, concomitant with memory impairment and neurodegeneration in adult mice. We found that the dendrite destabilizer Rho protein kinase 2 (Rock2), which accumulates in the brain of AD patients, is an APC/CCdh1 substrate in vivo and that Rock2 protein and activity increased in the cortex and hippocampus of Cdh1 cKO mice. In these animals, inhibition of Rock activity, using the clinical approved drug fasudil, prevented dendritic network disorganization, memory loss, and neurodegeneration. [Conclusions] APC/CCdh1-mediated degradation of Rock2 maintains the dendritic network, memory formation, and neuronal survival, suggesting that pharmacological inhibition of aberrantly accumulated Rock2 may be a suitable therapeutic strategy against neurodegeneration., The work was funded by The Instituto de Salud Carlos III (PI15/00473), FEDER (European regional development fund), and European Union’s Horizon 2020 Research and Innovation Programme Grant 686009, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

APC/C-Cdh1 promotes brain repair after ischemia through the RhoA-ROCK2 pathway

  • Agulla, Jesús
  • Lapresa, Rebeca
  • Almeida, Angeles
Resumen del trabajo presentado al Spanish Society of Biochemistry and Molecular Biology (SEBBM), celebrado en Madrid del 16 al 19 de julio de 2019., Stroke is a leading cause of long-term adult disability and a common cause of death in developed countries. Therefore, it is essential to establish new therapeutic strategies aimed at limiting and/or repairing ischemic neuronal damage. E3 ubiquitin ligase APC/C-Cdh1 is essential for neuronal survival. Previously, we described that Cdh1 regulates the balance between proliferation, neurogenesis and apoptosis. These processes play an essential role in the degeneration/repair balance after ischemic brain damage. Moreover, the cortical reorganization after stroke determines the recovery of the lost brain function. The RhoAROCK2 signalling pathway regulates the morphology, elongation and retraction of neurites, both axons and dendrites, making it an essential pathway in synaptic plasticity. Recently, we demonstrated that Cdh1 regulates the levels and activity of ROCK2 in cortical neurons and modulates the stability of dendrites and synapses. However, whether Cdh1 play a role in stroke remains unknown. To assess this issue, first we used an experimental in vitro model of ischemia/reoxygenation (I/R) and we found that Cdh1 modulates neuronal susceptibility through the RhoA-ROCK2 signalling pathway, since ROCK2 inhibition and knock-down reduced neuronal apoptosis induced by I/R. We also performed a middle cerebral artery occlusion (MCAO) in Cdh1-cKO and WT mice to assess the functional outcome after stroke. We found that Cdh1 is involved in the functional recovery after MCAO, favouring the reduction of infarct volume and the recovery of neurological functions. These results demonstrate that APC/C-Cdh1 actively participates in the neuronal response to I/R damage, enhancing neuronal survival through the RhoA-ROCK2 signalling pathway regulation. Thus, we have identified the Cdh1-ROCK2 axis as a key element in the pathogenesis of stroke and, therefore, as potential molecular targets for stroke treatment., Funded by The Instituto de Salud Carlos III (PI18/00265; RD16/0019/0018); European Regional Development Fund (FEDER); European Union's Horizon 2020 Research and Innovation Programme (Grant Agreement 686009); Junta de Castilla y Leon (IES007P17; Escalera de Excelencia CLU-2017-03 Cofinanciado por el P.O. FEDER de Castilla y Leon 14-20); and Bodegas R. Lopez de Heredia Viña Tondonia., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

P53 orchestrates the inflammatory response in an in vivo model of amyloid-beta-induced neurodegeneration

  • González-Guerrero, Sonia
  • Lapresa, Rebeca
  • Agulla, Jesús
  • Almeida, Angeles
Resumen del trabajo presentado al Spanish Society of Biochemistry and Molecular Biology (SEBBM), celebrado en Madrid del 16 al 19 de julio de 2019., Oligomerization of amyloid- (A ) peptides represents a central event in the etiopathology of Alzheimer's disease. Thus, AB oligomers trigger signalling cascades involving alteration of calcium homeostasis, production of reactive oxygen species, inflammatory processes and mitochondrial dysfunction, culminating in neuronal apoptosis. The basic stationary state of microglia is tolerant, prohomeostatic, and environmental monitoring. Accordingly, to a functional scale, microglial activity can be then categorized into a classical pro-inflammatory and neurotoxic phenotype, known as M1, and the alternative anti-inflammatory M2 phenotype involved in the resolution of inflammation, phagocytosis and tissue repair. Recently, our group have described a role of p53 in neurodegeneration in an experimental model of A -neurotoxicity. In addition to its traditional functions, p53 has recently emerged as a key modulator of the immune response in microglia. Therefore, we hypothesize that p53 could be modulating the activity pro le of the glia in response to AB oligomers. Here we evaluated the function of p53 in the inflammatory response to active A B25-35 oligomers leading to neurodegeneration, and the underlying mechanism. A B25-35 oligomers (9 nmol) were stereotaxically injected in the cerebral right ventricle of mice. We found that oligomerized AB25-35 triggered p53 accumulation leading to an early microglial activation. Besides, we found that p53 favours the characteristic morphological change of activated microglia and dictates the M1/M2 activity pro le. Moreover, the AB injection also increased the number of reactive astrocytes. Altogether, these events lead to dendrite disruption and neuronal death. Furthermore, these effects were prevented by genetic (p53 knockout mice) and pharmacologically (PFT-alpha) inhibition of p53. Our results highlight a key role of p53 in the AB -induced inflammatory response, which may contribute to neurodegeneration., This work was funded by The Instituto de Salud Carlos III (PI18/00265); European Regional Development Fund (FEDER); European Union's Horizon 2020 Research and Innovation Programme (Grant Agreement 686009); and Junta de Castilla y Leon (IES007P17; Escalera de Excelencia CLU-2017-03 Cofi nanciado por el P.O. FEDER de Castilla y Leon 14-20)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Brain neovascularization determines functional recovery after intracerebral hemorrhage through the p53 signaling pathway

  • Rodríguez González, Cristina
  • Carabias-Carrasco, Mónica
  • Resch-Beusher, Monica
  • Prieto, Estefanía
  • Almeida, Angeles
Resumen del trabajo presentado al Spanish Society of Biochemistry and Molecular Biology (SEBBM), celebrado en Madrid del 16 al 19 de julio de 2019., Intracerebral hemorrhage (ICH) is the most severe type of stroke and associates with high mortality rates and risk of disability of affected patients. So far there is no effective treatment, which, added to the lack of accurate prognosis, evidences the need to deepen the mechanisms that regulate brain repair after ICH.We previously shown that the human Tp53 Arg72Pro SNP modulates brain endothelial cells survival after ICH, which is essential for the secretion of growth factors and cytokines (i.e. VEGF) that mediate the mobilization of endothelial progenitor cells (EPCs) from the bone marrow to the peripheral blood. EPCs promote brain vascular repair after ICH, which is a vital response to restore oxygen supply and metabolic substrates in the ischemic brain. Then, pro-apoptotic p53 might be a negative regulator of EPC mobilization, thus affecting the functional prognosis after hemorrhagic stroke. Since p53 is accumulated in the brain after ICH, we speculate that p53 destabilization not only will promote cell survival, but also vascular recovery and brain repair. To con rm this hypothesis, p53 KO mice were subjected to an experimental in vivo model of ICH by injecting bacterial collagenase into the basal ganglia. We also analyzed proliferative markers and perfusion status of newlyformed brain blood vessels in the brain by Evans blue injection. We observed that p53 loss reduced lesion volume and increased levels of circulating EPCs. As a consequence, an improved vascular response was achieved in p53 KO mice, in comparison with those expressing an active p53 protein. Our results point out the impact of the p53 signaling pathway in the balance between brain damage and repair, which conditions functional recovery after ICH, suggesting p53 as a possible therapeutic target for hemorrhagic stroke., This work was funded by ISCIII (PI18/00265; RD16/0019/0018), European Regional Development Fund (FEDER), EU Horizon 2020 Research and Innovation Programme (Grant Agreement 686009), Junta de Castilla y Leon (IES007P17; Escalera de Excelencia CLU-2017-03 Cofinanciado por el P.O. FEDER de Castilla y Leon 14-20)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

WRAP53 fosters DNA repair and neuronal survival after ischemia

  • Sánchez Morán, Irene
  • Rodríguez González, Cristina
  • Almeida, Angeles
Resumen del trabajo presentado al Spanish Society of Biochemistry and Molecular Biology (SEBBM), celebrado en Madrid del 16 al 19 de julio de 2019., Ischemic stroke causes DNA damage in neurons, thereby contributing to cell death unless promptly repaired. An adequate DNA damage response is essential to survive after cerebral ischemia, therefore is indispensable to preserve the integrity of the transcribed genome in post-mitotic neurons; however, the molecular mechanism underlying neuronal survival remains unknown. Here we describe that WRAP53 (WD40 encoding RNA Antisense to p53), a scaffold protein implicated in telomere elongation and DNA repair in tumor cells, also plays an essential role in neuronal survival after ischemia. We observed that ischemia induces oxidative stress and promotes DNA damage, as revealed by the accumulation of yH2AX in neurons. The ischemic insult also promoted a time-dependent increase in Wrap53 gene expression and protein abundance. Remarkably, the ischemic-induced oxidative stress triggers WRAP53 traffic to the nucleus, where WRAP53 is involved in DNA repair processes. By siRNA analysis we confi rm that WRAP53 depletion prevents 53BP1 foci formation, therefore increasing neuronal susceptibility to ischemia-induced apoptosis, whereas WRAP53 expression in ischemic neurons promotes DNA repair events and cell survival. Our results demonstrate the relevance of nuclear accumulation of WRAP53 to maintain genome integrity in neurons and preserve neuronal survival after ischemia., This work was funded by The Instituto de Salud Carlos III (PI18/00265; RD16/0019/0018); European Regional Development Fund (FEDER); European Union's Horizon 2020 Research and Innovation Programme (Grant Agreement 686009); and Junta de Castilla y Leon (IES007P17)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilization

  • Lapresa, Rebeca
  • Agulla, Jesús
  • Almeida, Angeles
Resumen del trabajo presentado al Spanish Society of Biochemistry and Molecular Biology (SEBBM), celebrado en Madrid del 16 al 19 de julio de 2019., Neurodegeneration in selective brain areas underlies the pathology of Alzheimer's disease (AD). Although oligomeric amyloid-ß (Aß) plays a central role in the AD pathogenesis, the mechanism of neuronal loss in response to Aß remains elusive. The p53 tumor suppressor protein, a key regulator of cell apoptosis, has been described to accumulate in affected brain areas from AD patients. However, whether p53 plays any role in AD pathogenesis remains unknown. To address this issue, here we investigated the involvement of p53 on Aß-induced neuronal apoptosis. We found that exposure of neurons to oligomers of the amyloidogenic fragment 25-35 of the Aß peptide (Aß 25-35) promoted p53 protein phosphorylation and stabilization, leading to mitochondrial dysfunction and neuronal apoptosis. To address the underlying mechanism, we focused on cyclin dependent kinase-5 (Cdk5), a known p53-phosphorylating kinase. The results revealed that Aß 25-35 treatment activated Cdk5, and that inhibiting Cdk5 activity prevented p53 protein stabilization. Furthermore, Aß 25-35-mediated mitochondrial dysfunction and neuronal apoptosis were prevented by both genetic and pharmacological inhibition of either p53 or Cdk5 activities. This effect was mimicked with the full-length peptide A ß1-42. To confi rm the mechanism in vivo, Aß 25-35 was stereotaxically injected in the cerebral right ventricle of mice, a treatment that caused p53 protein accumulation, dendrite disruption and neuronal death. Furthermore, these effects were prevented in p53 knockout mice or by pharmacologically inhibiting p53. Thus, Aß 25-35 triggers Cdk5 activation to induce p53 phosphorylation and stabilization, which leads to neuronal damage. Inhibition of the Cdk5-p53 pathway may therefore represent a novel therapeutic strategy against Aß -induced neurodegeneration., This work was funded by The Instituto de Salud Carlos III (PI18/00265); European Regional Development Fund (FEDER); European Union's Horizon 2020 Research and Innovation Programme (Grant Agreement 686009); Junta de Castilla y Leon (IES007P17; Escalera de Excelencia CLU-2017-03 Co nanciado por el P.O. FEDER de Castilla y Leon 14-20); and Bodegas R. L opez de Heredia Viña Tondonia., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Abrogating mitochondrial ROS in neurons or astrocytes reveals cell-specific impact on mouse behaviour

  • Vicente-Gutiérrez, Carlos
  • Bonora, Nicoló
  • Jimenez-Blasco, Daniel
  • López-Fabuel, Irene
  • Bates, Georgina
  • Murphy, Michael P.
  • Almeida, Angeles
  • Bolaños, Juan P.
Cells naturally produce mitochondrial reactive oxygen species (mROS), but the in vivo pathophysiological significance has long remained controversial. Within the brain, astrocyte-derived mROS physiologically regulate behaviour and are produced at one order of magnitude faster than in neurons. However, whether neuronal mROS abundance differentially impacts on behaviour is unknown. To address this, we engineered genetically modified mice to down modulate mROS levels in neurons in vivo. Whilst no alterations in motor coordination were observed by down modulating mROS in neurons under healthy conditions, it prevented the motor dis- coordination caused by the pro-oxidant neurotoxin, 3-nitropropionic acid (3-NP). In contrast, abrogation of mROS in astrocytes showed no beneficial effect against the 3-NP insult. These data indicate that the impact of modifying mROS production on mouse behaviour critically depends on the specific cell-type where they are generated., J.P.B. is funded by the Agencia Estatal de Investigación (SAF2016-78114-R, PID2019-105699RB-I00/AEI/10.13039/501100011033 and RED2018-102576-T), Plan Nacional sobre Drogas (2020I028), ISCIII (CB16/10/00282), Junta de Castilla y León (Escalera de Excelencia CLU-2017-03), Ayudas Equipos Investigación Bio-medicina 2017 Fundación BBVA and Fundación Ramón Areces. A.A. is unded by the ISCIII (PI18/00265, RD16/0019/0018), AEI (PI18/00265, RD16/0019/0018) and European Union’s Horizon 2020 Research and Innovation Program (Grant Agreement 686009). J.P.B. and A.A. are fundedby the grant CSI151P20 from the Junta de Castilla y Leon., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Impact of p53 on the microglial response in an in vivo model of amyloid-beta-induced neurodegeneration

  • González Sánchez, Sergio
  • Lapresa, Rebeca
  • Agulla, Jesús
  • Almeida, Angeles
Resumen del trabajo presentado en el 43rd Annual Meeting of the Spanish Society of Biochemistry & Molecular Biology, celebrado en Barcelona, del 19 al 22 de julio de 2021, Alzheimer’s disease (AD) is a neurodegenerative disorder characterised by the presence of amyloid-β (Aβ) and Tau protein aggregates. Although research has classically focused on neuronal alterations, neuroinflammation has emerged as a key factor in AD pathophysiology. The main cellular components involved in the brain inflammatory process are glial cells. Aβ aggregates bind to pattern recognition receptors on microglia and astrocytes, whichtriggers an immune response that contributes to disease progres sion1,2. Functionally, microglia can be classified into M1 proinflammatory/neurotoxic or M2 anti-inflammatory/neuroprotective phenotypes 2. Previously, we described a key role for p53 in Aβ-induced neurodegeneration in vivo3. Recently, p53 has emerged as a modulator of the immune response in microglia4. Here, we evaluated the possible role of p53 as a modulator of the microglial response to Aβ25-35, leading to neurodegeneration., Funds: Instituto de Salud Carlos III (PI18/00265;RD16/0019/0018); FEDER; European Union’s Horizon2020 Research and Innovation Programme (GA 686009);Junta de Castilla y León (PhD grant co-financed by Fondo Social Europeo. EDU/601/2020)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

P53 orchestrates the microglial response upon amyloid-beta-induced neurodegeneration in vivo

  • González-Guerrero, Sonia
  • Lapresa, Rebeca
  • Agulla, Jesús
  • Almeida, Angeles
Trabajo presentado al 15th International Conference AD/PD 2021 celebrada de forma virtual del 9 al 14 de marzo de 2021, Amyloid-β (Aβ) oligomers trigger signalling cascades involving alteration of calcium homeostasis, ROS production, inflammatory processes and mitochondrial dysfunction, culminating in neuronal apoptosis. According to a functional scale, microglia can be categorized into the classical pro-inflammatory/neurotoxic phenotype, known as M1, and an alternative anti-inflammatory/neuroprotective M2 phenotype, which is involved in the resolution of inflammation, phagocytosis and tissue repair. Previously, we described a key role of p53 in neurodegeneration induced by Aβ neurotoxicity in vivo. Recently, p53 has emerged as a key modulator of the immune response in microglia. Here we evaluated whether p53 is modulating the microglial response to Aβ25-35 oligomers leading to neurodegeneration, Funded by The Instituto de Salud Carlos III (PI18/00265); European Union’s Horizon 2020 Research and Innovation Programme (Grant Agreement 686009) and Programa Operativo FSE Castilla y León 2014-2020.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

ROS-induced Sp1 regulates Wrap53 levels and nuclear accumulation leading to neuroprotection after ischemia

  • Martínez-Peralta, S.
  • Sánchez Morán, Irene
  • Rodríguez González, Cristina
  • Almeida, Angeles
Resumen del trabajo presentado en el 19 Congreso Nacional de la SENC celebrado en Lleida del 3 al 5 de noviembre de 2021, Ischemia-induced oxidative stress compromises genome integrity, which results in DNA damage and neuronal loss after stroke. We described that reactive oxygen species (ROS) generated during ischemia upregulate WRAP53 (WD40 encoding RNA antisense to p53) and trigger its translocation to the nucleus, where it promotes DNA repair [1]. However, the molecular mechanism remains unknown. Transcription factor Sp1 acts as a pleiotropic oxidative stress response protein in neurons. Particularly, ROS-induced Sp1 expression promotes neuroprotection against ischemia [2].i nterestingly, Wrap53 promoter contains putative consensus sequences (GC boxes) for Sp1. We analyze the role of Sp1 as a modulating factor of WRAP53-mediated neuronal survival and its impact on brain repair after stroke., Funded:ISCIII (FI19/00160;PI18/00265;RD16/0019/0018), FEDER, EU Horizon 2020 Research and Innovation Programme (Grant Agreement 686009), Junta de Castilla y León (CSI151P20;Escalera de Excelencia CLU-2017-03 Cofinanciado por P.O.FEDER de Castilla y León 14-20)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Contribución de congreso (ConferenceOutput)

Targeting mitochondrial p53 as a novel therapeutic approach for the treatment of Alzheimer`s Disease

  • Lapresa, Rebeca
  • Agulla, Jesús
  • Almeida, Angeles
Trabajo presentado ene el 15th International Conference AD/PD 2021, celerado on line del 9 al 14 de marzo de 2021, [Aims] Alzheimer’s disease (AD) is a complex multifactorial disease in which neural death occurs predominantly by apoptosis. The p53 protein functions as a key regulator of apoptosis and accumulates in brains from AD patients. This protein naturally occurs in humans in two functional polymorphic variants, resulting in Arg or Pro at residue 72, which regulates p53 apoptotic activity. Here we evaluate the relevance of the p53 Arg72Pro single nucleotide polymorphism (SNP) in Amyloid-β(Aβ)-induced neurotoxicity both in vitro and in vivo., [Methods] We used primary cortical neurons from humanized Tp53 Arg72Pro knock-in mice treated with Aβ oligomers (10 μM) and an Aβ (5 nmol) intracerebroventricular injection model in Tp53 Arg72Pro knock-in mice to assess mitochondrial function, neurodegeneration and cognitive status., [Results] We found that the Arg genotype increased neuronal susceptibility to Aβ toxicity upon p53 mitochondrial stabilization in vitro. Accordingly, Arg72 mice were more susceptible to Aβ- induced neurodegeneration and memory loss than Pro72 mice. Interestingly, treatment with PFTμ (40 mgKg-1), a small molecule that inhibits p53 mitochondrial binding without affecting its transactivation activity, prevented Aβ-induced memory deficit in Arg72 mice, [Conclusions] Our results demonstrate that blocking the p53-mitochondria interaction prevents cognitive decline in Aβ-injected mice. Moreover, PFTμ may be useful to develop novel therapeutic approaches for AD, especially in patients carrying the Arg72 SNP variant, Funded by Instituto de Salud Carlos III (PI18/00265; RD16/0019/0018); FEDER; European Union’s Horizon 2020 Research and Innovation Programme (Grant Agreement 686009) and Junta de Castilla y León (Escalera de Excelencia (CLU-2017-03 Cofinanciado por el P.O. FEDER de Castilla y León).